Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death
Visco, Carlo;Tecchio, Cristina;Merli, Michele;Ruggeri, Marco;
2019-01-01
Abstract
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Visco_et_al-2018-British_Journal_of_Haematology(2).pdf
accesso aperto
Tipologia:
Documento in Pre-print
Licenza:
Accesso ristretto
Dimensione
135.92 kB
Formato
Adobe PDF
|
135.92 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
